Paula Albuquerque

Paula Albuquerque

Assets Strategic Planning UCB
Paula Albuquerque

Paula has 20 years of experience with a comprehensive US and ex-US global background within the healthcare, pharmaceutical, biotech, and management consulting sectors. She is known as an innovative, strategic and motivational leader with a passion for driving enhanced and sustainable access to healthcare and medicines for all individuals. Paula’s work helps illuminate future opportunities as well as challenges for how innovation can be brought to market in an affordable way because of the value the health solution creates to the specific ecosystem - patients, caregivers, health systems, markets, companies, and society – is fully considered. Therefore, her work paves the way for responsive adoption when innovation is launched and for universal sustainable funding, so that all patients who stand to benefit from the new health solutions are included. Paula’s areas of expertise span across industry value chain including Strategic Planning, Launch and Operational Excellence, Market Access, Price and Negotiations. She has a proven track record in leading Global, Regional and Local product launches, initially as a consultant and after working in the Pharmaceutical Industry in different roles, teams and therapeutic areas. Paula brings a unique approach to her leadership and work combining a Doctorate in Pharmacy and business acumen gained through education (INSEAD Chief Strategy Officer Programme, Executive MBA at IESE and MSc in Health Economics at University Pompeu Fabra), practical experience in international, multi-lingual and cross-cultural pharmaceutical/biotech/consulting industries (UCB Biopharma, Almirall S.A., McCann Health) and from living abroad in the UK, Spain and Belgium. Paula is originally from Portugal and in the last six years she is living in Belgium with her family.

Pharma Launch Excellence Summit Main Conference Day 1: Wednesday 2nd December

9:30 AM Panel Discussion: Building an Evidence-Based Package to Secure Premium Pricing & Reimbursement in Different Markets

As pricing and reimbursement scrutiny intensifies, demonstrating value through robust evidence has never been more important. This panel will explore how launch excellence teams can develop compelling evidence packages that meet diverse payer expectations, support premium pricing, and maximise reimbursement across global markets. 

• Identifying what evidence is required to create a narrative that secures reimbursement and premium pricing – how does this evidence differ in markets around the world?
• Using data from comparative studies, benchmarking analyses and health economic models to support premium pricing and payer acceptance
• Learning how to ensure product value is effectively demonstrated and maintained in pricing discussions throughout the value chain to demonstrate value and return on investment

Check out the incredible speaker line-up to see who will be joining Paula.

Download The Latest Agenda